NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) —

Sleep Number Corporation SNBR

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of Sleep Number shareholders alleging that the defendants made false and misleading statements and failed to disclose the following: (i) Sleep Number experienced a severe disruption in its supply chain as a result of the winter for foam suffered storm Uri; (ii) Sleep Number did not have the supply chain flexibility, redundancies and resiliency as presented to investors sufficient to offset the foam supply disruption caused by Winter Storm Uri; (iii) because foam was a necessary ingredient in the production of Sleep Number’s primary mattress products, Sleep Number’s ability to fulfill customer orders in a timely manner had been materially impaired; (iv) as a result, Sleep Number was unable to meet increasing customer demand for Sleep Number’s products; and (v) as a result, Sleep Number was forced to delay shipments of mattresses to end users, pushing multi-million dollar sales into subsequent quarters and adversely affecting Sleep Number’s financial results.

If you are a Sleep Number investor and would like more information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@jlclasslaw.com.

Organogenesis Holdings, Inc. OR WALK

Lifshitz Law PLLC announces that a class action lawsuit has been filed on behalf of Organogenesis shareholders alleging that the defendants made materially false and misleading statements about the Company’s business, operations and prospects. Specifically, the Defendants have made false and/or misleading statements and/or failed to disclose the following: (i) Organogenesis unlawfully billed the federal government for its Affinity and PuraPly XT products, including by charging the price of those products many times higher have Similar products; (ii) the Company has unreasonably caused physicians to test its…